Why INR is outside the therapeutic range in patients with acuteischemic stroke and atrial fibrillation

Introduction: Warfarin is still the primary drug used to prevent vascular events in patientswith atrial fibrillation (AF), especially in low-income countries. Therapeutic failure and non-adherenceare common causes of recurrent embolic events. The aim of this study was toinvestigate possible reasons...

Full description

Saved in:
Bibliographic Details
Main Authors: Elyar Sadeghi Hokmabadi, Sheida Shaafi, Yalda Sadeghpour, Reza Deljavan, Javad Jalili, Morteza Ghojazadeh, Elyar Alizade Najmi, Saeid Charsouei, Mehdi Farhoudi
Format: Artigo
Language:Inglês
Published: Tabriz University of Medical Sciences Press 2022-04-01
Series:Journal of Research in Clinical Medicine
Subjects:
cardio-embolic stroke
atrial fibrillation
warfarin
anticoagulants
neurologic manifestation
Online Access:https://jrcm.tbzmed.ac.ir/PDF/jrcm-10-6.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items